These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 29901826)

  • 1. Use of point-of-care HbA
    Andersen JW; Dahl M; Yderstraede KB; Hoegh A
    Diabet Med; 2018 Jun; ():. PubMed ID: 29901826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevance of the Viborg Population Based Screening Programme (VISP) for Cardiovascular Conditions Among 67 Year Olds: Attendance Rate, Prevalence, and Proportion of Initiated Cardiovascular Medicines Stratified By Sex.
    Dahl M; Lindholt J; Søgaard R; Refsgaard J; Svenstrup D; Moeslund NJ; Bredsgaard M; Høgh A
    Eur J Vasc Endovasc Surg; 2023 Jul; 66(1):119-129. PubMed ID: 36931553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protocol for a cohort study to evaluate the effectiveness and cost-effectiveness of general population screening for cardiovascular disease: the Viborg Screening Programme (VISP).
    Høgh A; Lindholt JS; Søgaard R; Refsgaard J; Svenstrup D; Moeslund NJ; Bredsgaard M; Dahl M
    BMJ Open; 2023 Feb; 13(2):e063335. PubMed ID: 36854592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Quality of Diabetes Care Based Upon Individualised Treatment Goals - A Cross Sectional Study in 4784 Patients in Germany.
    Kloos C; Müller N; Hartmann P; Lehmann T; Sämann A; Roth J; Wolf G; Müller UA
    Exp Clin Endocrinol Diabetes; 2016 May; 124(5):294-9. PubMed ID: 26824283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular and renal burdens of prediabetes in the USA: analysis of data from serial cross-sectional surveys, 1988-2014.
    Ali MK; Bullard KM; Saydah S; Imperatore G; Gregg EW
    Lancet Diabetes Endocrinol; 2018 May; 6(5):392-403. PubMed ID: 29500121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between participation in a brief diabetes education programme and glycaemic control in adults with newly diagnosed diabetes.
    Weaver RG; Hemmelgarn BR; Rabi DM; Sargious PM; Edwards AL; Manns BJ; Tonelli M; James MT
    Diabet Med; 2014 Dec; 31(12):1610-4. PubMed ID: 24890340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of type 1 diabetes on maternal long-term risk of hospitalisation and mortality: a nationwide combined clinical and register-based cohort study (The EPICOM study).
    Knorr S; Juul S; Bytoft B; Lohse Z; Clausen TD; Jensen RB; Damm P; Beck-Nielsen H; Mathiesen ER; Jensen DM; Gravholt CH
    Diabetologia; 2018 May; 61(5):1071-1080. PubMed ID: 29478097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International comparison of glycaemic control in people with type 1 diabetes: an update and extension.
    Prigge R; McKnight JA; Wild SH; Haynes A; Jones TW; Davis EA; Rami-Merhar B; Fritsch M; Prchla C; Lavens A; Doggen K; Chao S; Aronson R; Brown R; Ibfelt EH; Svensson J; Young R; Warner JT; Robinson H; Laatikainen T; Rautiainen P; Delemer B; Souchon PF; Diallo AM; Holl RW; Schmid SM; Raile K; Tigas S; Bargiota A; Zografou I; Luk AOY; Chan JCN; Dinneen SF; Buckley CM; Kgosidialwa O; Cherubini V; Gesuita R; Strele I; Pildava S; Veeze H; Aanstoot HJ; Mul D; Jefferies C; Cooper JG; Løvaas KF; Battelino T; Dovc K; Bratina N; Eeg-Olofsson K; Svensson AM; Gudbjornsdottir S; Globa E; Zelinska N
    Diabet Med; 2022 May; 39(5):e14766. PubMed ID: 34890078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of diabetes duration on the relationship between glycaemic control and risk of death in older adults with type 2 diabetes.
    Ghouse J; Isaksen JL; Skov MW; Lind B; Svendsen JH; Kanters JK; Olesen MS; Holst AG; Nielsen JB
    Diabetes Obes Metab; 2020 Feb; 22(2):231-242. PubMed ID: 31596048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mean HbA
    Forbes A; Murrells T; Mulnier H; Sinclair AJ
    Lancet Diabetes Endocrinol; 2018 Jun; 6(6):476-486. PubMed ID: 29674135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of population-level HbA
    Young KG; McGovern AP; Barroso I; Hattersley AT; Jones AG; Shields BM; Thomas NJ; Dennis JM
    Diabetologia; 2023 Feb; 66(2):300-309. PubMed ID: 36411396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Undiagnosed diabetes: Prevalence and cardiovascular risk profile in a population-based study of 52,856 individuals. The HUNT Study, Norway.
    Bjarkø VV; Haug EB; Sørgjerd EP; Stene LC; Ruiz PL; Birkeland KI; Berg TJ; Gulseth HL; Iversen MM; Langhammer A; Åsvold BO
    Diabet Med; 2022 Jun; 39(6):e14829. PubMed ID: 35288977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of periodontitis for glycaemic control in people with diabetes mellitus.
    Simpson TC; Clarkson JE; Worthington HV; MacDonald L; Weldon JC; Needleman I; Iheozor-Ejiofor Z; Wild SH; Qureshi A; Walker A; Patel VA; Boyers D; Twigg J
    Cochrane Database Syst Rev; 2022 Apr; 4(4):CD004714. PubMed ID: 35420698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical impact of an integrated e-health system for diabetes self-management support and shared decision making (POWER2DM): a randomised controlled trial.
    Ruissen MM; Torres-Peña JD; Uitbeijerse BS; Arenas de Larriva AP; Huisman SD; Namli T; Salzsieder E; Vogt L; Ploessnig M; van der Putte B; Merle A; Serra G; Rodríguez G; de Graaf AA; de Koning EJP; Delgado-Lista J; Sont JK;
    Diabetologia; 2023 Dec; 66(12):2213-2225. PubMed ID: 37775611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Prediabetes and Undiagnosed Diabetes in Canada (2007-2011) According to Fasting Plasma Glucose and HbA1c Screening Criteria.
    Rosella LC; Lebenbaum M; Fitzpatrick T; Zuk A; Booth GL
    Diabetes Care; 2015 Jul; 38(7):1299-305. PubMed ID: 25852207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia.
    Richter B; Hemmingsen B; Metzendorf MI; Takwoingi Y
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD012661. PubMed ID: 30371961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
    Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
    Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metformin.
    Shepherd MH; Shields BM; Hudson M; Pearson ER; Hyde C; Ellard S; Hattersley AT; Patel KA;
    Diabetologia; 2018 Dec; 61(12):2520-2527. PubMed ID: 30229274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA.
    Rosenstock J; Frias J; Jastreboff AM; Du Y; Lou J; Gurbuz S; Thomas MK; Hartman ML; Haupt A; Milicevic Z; Coskun T
    Lancet; 2023 Aug; 402(10401):529-544. PubMed ID: 37385280
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.